Apoptosis of Dalton's lymphoma due to in vivo treatment with emodin is associated with modulations of hydrogen peroxide metabolizing antioxidant enzymes

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 439-449

  Singh, Krishna Beer ^a   Trigun, Surendra Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antioxidant enzymes; Apoptosis; Catalase; Dalton's lymphoma; Emodin; Glutathione peroxidase; Superoxide dismutase

Indexed keywords

MUS;

ANTINEOPLASTIC AGENT; ANTIOXIDANT; EMODIN; HYDROGEN PEROXIDE;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; ENZYMOLOGY; LIVER; LONGEVITY; METABOLISM; MOUSE; PATHOLOGY; T CELL LYMPHOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; EMODIN; HYDROGEN PEROXIDE; LIVER; LONGEVITY; LYMPHOMA, T-CELL; MICE;

EID: 84886585187     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9305-2     Document Type: Article

References (49)

1. Koiri, R. K., Trigun, S. K., Mishra, L., Panday, K., Dixit, D., & Dubey, S. K. (2009). Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand. Investigational New Drugs, 27, 503-516.
2. Lopez-Lazaro, M. (2010). A new view of carcinogenesis and an alternative approach to cancer therapy. Molecular Medicine, 16, 144-153.
3. Dyson, P. J., & Sava, G. (2006). Metal based anti tumor drugs in the post genomic era. Dalton Transactions, 16, 1929-1933.
4. Koiri, R. K., & Trigun, S. K. (2011). Dimethyl sulfoxide activates tumor necrosis factor α-p53 mediated apoptosis and down regulates d-fructose-6-phosphate-2-kinase and lactate dehydrogenase-5 in Dalton's lymphoma in vivo. Leukemia Research, 35, 950-956.
5. Wilson, R. M., & Danishefsky, S. J. (2006). Small molecule natural products in the discovery of therapeutic agents: The synthesis connection. The Journal of Organic Chemistry, 71, 8329-8351.
6. Kwak, H. J., Park, M. J., Park, C. M., Moon, S. I., Yoo, D. H., Lee, S. H., et al. (2006). Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-(KDR/Flk-1) phosphorylation. Intenational Journal of cancer, 118, 2711-2720.
7. Muto, A., Hori, M., Sasaki, Y., Saitoh, A., Yasuda, I., Maekawa, T., et al. (2007). Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. Molecular Cancer Therapeutics, 6, 987-994.
8. Srinivas, G., Babykutty, S., Sathiadevan, P. P., & Srinivas, P. (2007). Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent. Medicinal Research Reviews, 5, 591-601.
9. Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473, 117-125.
10. Huang, Z., Chen, G., & Shi, P. (2008). Emodin-induced apoptosis in human breast cancer BCap-37 cells through the mitochondrial signaling pathway. Archives of Pharmacal Research, 31, 742-748.
11. Rahimipour, S., Bilkis, I., Peron, V., Gescheidt, G., Barbosa, F., Mazur, Y., et al. (2001). Generation of free radicals by emodic acid and its [d-Lys6]GnRH-conjugate. Photochemistry and Photobiology, 74, 226-236.
12. Weydert, C. J., Waugh, T. A., Ritchie, J. M., Iyer, K. S., Smith, J. L., Li, L., et al. (2006). Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radical Biology and Medicine, 41, 226-237.
13. Kim, J. W., Gardner, L. B., & Dang, C. V. (2005). Oncogenic alternations of metabolism and the Warburg effect. Drug Discovery Today, 2, 233-238.
14. Szatrowski, T. P., & Nathan, C. F. (1991). Production of large amounts hydrogen peroxide by human tumor cells. Cancer Research, 51, 794-800.
15. 2 mediate the differential susceptibility of cancer cells versus normal cells of glucose deprivation. Biochemical Journal, 418, 29-37.
16. Li, S., Yan, T., Yang, Ji.-Q., Oberley, T. D., & Oberley, L. W. (2000). The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Research, 60, 3927-3939.
17. Erker, L., Schubert, R., Elchuri, S., Huang, T. T., Tarin, D., Mueller, K., et al. (2006). Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice. Free Radical Biology and Medicine, 41, 590-600.
18. Aquilano, K., Viqilanza, P., Ratillio, G., & Ciriolo, M. R. (2006). Mitochondrial damage due to SOD1 deficiency in SH-SY5Y neuroblastoma cells: A rationale for the redundancy of SOD1. The FASEB Journal, 20, E930-E941.
19. Tanaka, M., Kogawa, K., Nishinori, Y., Kuribayashi, K., Nakamura, K., Muramastu, H., et al. (1997). Suppression of intracellular Cu-Zn SOD results in enhanced motility and metastasis of Meth A sarcoma cells. International Journal of Cancer, 73, 187-192.
20. Li, N., Oberley, T. D., Oberley, L. W., & Zhong, W. (1998). Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate, 35, 221-233.
21. Zhang, Y., Zhao, W., Zhang, H. J., Domann, F. E., & Oberley, L. W. (2002). Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Research, 62, 1205-1212.
22. Amstad, P., Peskin, A., Shah, G., Mirault, M. E., Moret, R., Zbinden, I., et al. (1991). The balance between Cu-Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry, 30, 9305-9313.
23. Amstad, P., Moret, R., & Cerutti, P. (1994). Glutathione peroxidase compensates for the hypersensitivity of Cu-Zn-superoxide dismutase overproducers to oxidant stress. The Journal of Biological Chemistry, 269, 1606-1609.
24. Prasad, S. B., & Giri, A. (1999). Effect of cisplatin on the lactate dehydrogenase activity and its isozyme pattern in Dalton's lymphoma bearing mice. Cytologia (Tokyo), 64, 259-267.
25. Prasad, S. B., & Giri, A. (1994). Antitumor effect of cisplatin against murine ascites Dalton's lymphoma. Indian Journal of Experimental Biology, 32, 155-162.
26. Khynriam, D., & Prasad, S. B. (2003). Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma. Mutation Research, 526, 9-18.
27. Koiri, R. K., Trigun, S. K., Dubey, S. K., Singh, S., & Mishra, L. (2008). Metal Cu(II) and Zn (II) bipyridyls as inhibitors of lactate dehydrogenase. BioMetals, 21, 117-126.
28. Singh, S., Koiri, R. K., & Trigun, S. K. (2008). Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum. Neurochemical Research, 33, 103-113.
29. Trigun, S. K., Koiri, R. K., Mishra, L., Dubey, S. K., Singh, S., & Pandey, P. (2007). Ruthenium complex as enzyme modulator: Modulation of lactate dehydrogenase by a novel ruthenium (II) complex containing 4-Corboxy N-Ethylbezamide as a ligand. Current Enzyme Inhibition, 3, 243-253.
30. Bergmeyer, H. U. (1974). Methods of enzymatic analysis. New York: Academic press Inc.
31. Singh, S., & Trigun, S. K. (2010). Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway. Cerebellum, 9, 384-397.
32. Lowry, O. H., Rosebrough, N. J., Farr, L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry, 193, 267-275.
33. Jahnke, G. D., Price, C. J., Marr, M. C., Myers, C. B., & George, J. D. (2004). Developmental toxicity evaluation of emodin in rats and mice. Birth Defects Research (Part B), 71, 89-101.
34. Cha, T.-L., Qiu, L., Chen, C.-T., Wen, Y., & Hung, M.-C. (2005). Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research, 65, 2287-2295.
35. Shuang-suo, D., Xin, Z., Xiao-li, J., Yan-an, C., Ping, S., En-qi, L., et al. (2008). Protective effects of emodin and astragalus polysaccharides on chronic hepatic injury in rats. Chinese Medical Journal, 121, 1010-1014.
36. Gaiddon, C., Jeannequin, P., Bischoff, P., Pferrer, M., Sirlin, C., & Loeffler, J. P. (2005). Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-independent mechanisms. Journal of Pharmacology and Experimental Therapeutics, 315, 1403-1411.
37. Jiang, X., & Wang, X. (2004). Cytochrome c mediated apoptosis. Annual Review of Biochemistry, 73, 87-106.
38. Heimlich, G., MCKinnon, A. D., Bernardo, K., Brdiczka, D., Reed, J. C., Renate, K. R., et al. (2004). Bax-induced cytochrome c release from mitochondria depends on α-helices-5 and -6. Biochemical Journal, 378, 247-255.
39. 53-dependent pathways of apoptosis. Cell Death and Differention, 8, 1049-1051.
40. Chen, Y. C., Shen, S. C., Lee, W. R., Hsu, F. L., Lin, H. Y., Ko, C. H., et al. (2002). Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochemical Pharmacology, 64, 1713-1724.
41. Su, Y. T., Chang, H. L., Shyue, S. K., & Hsu, S. L. (2005). Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochemical Pharmacology, 70, 229-241.
42. Jing, X., Ueki, N., Cheng, J., Imanishi, H., & Hada, T. (2002). Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Japanese Journal of Cancer Research, 2002(93), 874-882.
43. Yi, J., Yang, J., He, R., Gao, F., Sang, H., Tang, X., et al. (2004). Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Research, 64, 108-116.
44. Valentine, J. S. (2002). Do oxidatively modified proteins cause ALS? Free Radical Biology and Medicine, 3, 1314-1320.
45. Lopez-Lazaro, M. (2007). Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Letters, 252, 1-8.
46. Ajith, T. A., & Janardhanan, K. K. (2003). Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. Journal of Ethanopharmacology, 84, 157-162.
47. Sava, G., Pacor, S., Bergamo, A., Cocchietto, M., Mestroni, G., & Alessio, E. (1995). Effects of ruthenium complexes on experimental tumors: Irrelevance of cytotoxicity for metastasis inhibition. Chemico-Biological Interactions, 95, 109-126.
48. Shieh, D. E., Chen, Y. Y., Yen, M. H., Chiang, L. C., & Lin, C. C. (2004). Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sciences, 74, 2279-2290.
49. Fraiser, L. H., Kanekal, S., & Kehrer, J. P. (1991). Cyclophosphamide toxicity. Charactering and avoiding the problem. Drugs, 42, 781-795.